Are you ready to navigate the complexities of post-approval drug lifecycle management? Discover the strategies for success in our latest white paper, “Effective Strategies for Post-Approval Lifecycle Management and Local Pharmacovigilance,” authored by IQVIA’s experts. Discover how to overcome common regulatory challenges, implement effective regulatory strategies, and leverage partnerships for post-approval success. Gain insights into the role of Local Qualified Persons for Pharmacovigilance (LQPPVs) and how they are integral to maintaining compliance and fostering innovation across global markets. Unlock the full potential of your post-approval processes by reading our comprehensive guide: https://bit.ly/3CQC66b #Pharmacovigilance #RegulatoryAffairs #DrugLifecycleManagement #LQPPV #LCM
IQVIA Safety & Regulatory Compliance
医院和医疗保健
Danbury and Durham，Connecticut and North Carolina 20,163 位关注者
End-to-end integrated tech services and analytics solutions for safety, regulatory, quality and commercial compliance
关于我们
IQVIA has a vision that goes beyond simply optimizing individual safety, regulatory, quality, and compliance functions. Using cloud-based technology combined with advanced analytics—including artificial intelligence and machine learning—IQVIA is bringing together global regulatory intelligence, safety data, product quality information and legal/ethical guidance on an integrated platform. For customers, this means: ? Improved compliance performance at lower cost across all functions ? Visibility across their complete compliance landscape ? Faster response times ? More predictive planning, throughout the product lifecycle Learn more are: www.iqvia.com/GlobalCompliance
- 网站
-
https://www.iqvia.com/GlobalCompliance
IQVIA Safety & Regulatory Compliance的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 超过 10,001 人
- 总部
- Danbury and Durham，Connecticut and North Carolina
- 领域
- commercial compliance、safety compliance、regulatory compliance、quality compliance和compliance
动态
-
Did you know that a proactive approach to artwork creation in preclinical stages helps avoid common mistakes, maximize drug potential, and bring treatments to market faster? From competitor label analysis and aspirational label claims to TPP guidance and early regulatory engagement, IQVIA’s Rama Mohan Rao Chikkam discusses how drug developers can make more informed labelling decisions. Read his insights in full. https://bit.ly/3ZbCXpz #drugdevelopment #labeling
-
-
In the second installment of the 'Silos to Synergy' series, our experts delve into the paradox of data overabundance, methods for measuring technological effectiveness, and the critical need for robust data management and literacy. Dive in now! https://bit.ly/4eMKAZf #Qualitymanagement #datamanagement
-
-
Are you ready to unlock the future of drug development using AI/ML? Are you monitoring the current regulatory landscape for guidance on using GenAI in clinical trials? IQVIA’s Patrick Brady, PharmD, explores the transformative potential of AI and machine learning (ML) in clinical trials. The new white paper provides valuable insights into how global health authorities are shaping the regulatory framework and offers practical guidance on leveraging AI/ML to improve trial efficiency, design, and outcomes. Stay updated on emerging regulatory expectations and enhancing clinical trials: https://bit.ly/3ZqtHzc #drugdevelopment #GenAI #regulatorystrategy #regulatoryaffairs
-
-
1.5 billion hours of medical audio data annually. Are your safety operations ready to handle it? IQVIA’s next-gen AI solutions streamline safety workflows – reducing manual burden and ensuring no adverse event goes unnoticed. Discover how automation is transforming pharmacovigilance. Read the full blog here: https://bit.ly/4g94xKP #SafetyPV #Pharmacovigilance
-
-
Register Now: AI & QARA for APAC Webinar on December 4th! Join us for an insightful webinar where industry leaders from Dentsply Sirona, Cynosure, and IQVIA will explore how Artificial Intelligence (AI) is revolutionizing Quality Assurance and Regulatory Affairs (QARA) in the Asia-Pacific (APAC) region. In the rapidly evolving landscape of Quality Assurance and Regulatory Affairs (QARA), the integration of Artificial Intelligence (AI) is transforming how businesses operate, especially in the Asia-Pacific (APAC) region. Discover practical applications and gain valuable insights from experts Dentsply Sirona’s Asheeta Anand, Cynosure’s Jeremy Yung, IQVIA’s Michael King and Varna A. Don't miss out on this opportunity to stay ahead in the rapidly evolving QARA landscape.?Register today! https://lnkd.in/ePbF4QpE #QARA #IQVIAAPAC
-
-
From 2010-2023, Pharmaceutical case processing saw a 220% surge in reported AEs – marking an urgent need for innovative solutions that leverage advanced automation. IQVIA’s Uwe Trinks explores how #GenAI can streamline data collection and improve the accuracy of case processing. https://bit.ly/4i06Phr
-
-
Reaching the post-approval phase is a significant milestone for pharma companies, but it comes with its own set of challenges. IQVIA’s Marcela Mi?o, Global Head of Lifecycle Management for Marketed Products, shares insights on effective post-approval lifecycle management. Discover how planning, communication, and leveraging cutting-edge technologies can drive commercial success. Read the full article to learn more: https://bit.ly/3BbFNTo #LifecycleManagement #RegulatoryStrategy #RegulatoryAffairs
-
-
Pharmacovigilance is evolving, with AI and NLP leading the way! By analyzing unstructured data from social media and patient reports, we're uncovering hidden safety signals to enhance patient care. Learn more about this exciting revolution in monitoring drug safety with IQVIA’s Deepanshu Saini. https://bit.ly/4fOcOo4
-
-
From clean data sets to successful algorithms, companies are under increasing pressure to provide more transparency to patients across the board. In the upcoming rerun of our insightful LinkedIn live, Gabriel Adusei discusses the need for any tech utilizing AI to be symbolized. Find out more… https://bit.ly/3OrWX2i #QARA